Models
NECTAR LIFESCIENCES LTD.NECLIFE
-10per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model(10)implied P/B (0.33)× on FY26 book
Against CMP ₹10.86190.2%close of 2026-09-20
Cost of equity12.83%risk-free + beta × equity risk premium
Book equity, FY2630per share · excess returns add ₹(40)
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Excess-return schedule · ₹ crore · book equity earns your ROE; value is book plus the returns above the cost of equity

₹ croreFY27FY28FY29FY30FY31
Opening book equity5822891447136
Net income at -50.3% ROE(293)(145)(72)(36)(18)
Cost of equity charge at 12.83%(75)(37)(18)(9)(5)
Excess return(367)(183)(91)(45)(22)
Present value(346)(152)(67)(30)(13)
Closing book equity289144713618
Book equity today582
PV of 5 years of excess return(608)
PV of the terminal excess return, 5% flat(164)
add non-operating investments0
Equity value(190)
÷ 19.43 crore shares(10)
ROE is at or below the cost of equity, so every year destroys value against book and the model lands below book value. That is the arithmetic, not a view.

Where the methods land · ₹ per share · the dashed line is the CMP

52-week rangetraded range, a fact not a value
922

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingExcess returnROE -50.3%12.83%5%(10)(190.2)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.